Location Toronto, Ontario, Canada Regions Great Lakes Gender Male
Investor Type Number of Exits
Marc Lustig is the current Chief Executive Officer and Chairman of PharmaCielo. He previously worked at Origin House as a Chief Executive Officer.
Overview
Personal Investments
Announced Date | Organization Name | Lead Investor | Funding Round | Money Raised |
|---|---|---|---|---|
 Pulp Culture | Series A - Pulp Culture | |||
 IM Cannabis | Post-IPO Equity - IM Cannabis | |||
 Tryptamine Therapeutics | Post-IPO Equity - Tryptamine Therapeutics |
Partner Investments
Announced Date | Organization Name | Investor Name | Lead Investor | Funding Round | Money Raised |
|---|---|---|---|---|---|
 Cult Food Science |  L5 Capital | Post-IPO Equity - Cult Food Science | |||
 Anandia Labs |  Origin House | Venture Round - Anandia Labs |
Exits
- Tryptamine Therapeutics
Tryp Identifying and developing clinical-stage compounds for orphan diseases and other diseases with high unmet medical needs. - IM Cannabis
IM Cannabis is a manufacturing company that produces medical-grade cannabis for both local and international clients.
Organization Name | Title At Company | Start Date | End Date |
|---|---|---|---|
Origin House |
Board and Advisor Roles
Recent News and Activity
Pulp Culture raised from Alexis Ohanian and 9 other investors
IM Cannabis raised from Marc Lustig and Oren Shuster
